Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Wendy B London Alice L Yu Barry Shulkin John M. Maris |
| Publication date | May 23, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |